Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Current Assets (2016 - 2025)

Bio Key International's Current Assets history spans 16 years, with the latest figure at $3.7 million for Q3 2025.

  • For Q3 2025, Current Assets fell 17.68% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, down 17.68%, while the annual FY2024 figure was $1.9 million, 28.04% down from the prior year.
  • Current Assets for Q3 2025 was $3.7 million at Bio Key International, down from $4.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $17.7 million in Q1 2021 and bottomed at $1.9 million in Q4 2024.
  • The 5-year median for Current Assets is $5.9 million (2023), against an average of $8.2 million.
  • The largest annual shift saw Current Assets skyrocketed 790.95% in 2021 before it plummeted 70.82% in 2023.
  • A 5-year view of Current Assets shows it stood at $14.0 million in 2021, then tumbled by 35.88% to $9.0 million in 2022, then tumbled by 70.82% to $2.6 million in 2023, then decreased by 28.04% to $1.9 million in 2024, then skyrocketed by 98.52% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Current Assets are $3.7 million (Q3 2025), $4.0 million (Q2 2025), and $4.6 million (Q1 2025).